Positive Quality Intervention: Androgen Deprivation Therapy with Relugolix (Orgovyx®) g parameters, and patient management strategies to maximize medication adherence and improve patient

Apr 21, 2021 · Recent therapeutic advancements have significantly improved outcomes and prolonged survival in patients with advanced disease. As such, the management and mitigation of ADT-related …

Sep 26, 2025 · Patients on Firmagon (degarelix) for androgen deprivation therapy should be monitored regularly for testosterone suppression, PSA levels, bone health, cardiovascular risk factors, anemia, …

Dec 23, 2024 · Many prostate cancer patients receiving androgen deprivation therapy (ADT) are not undergoing recommended monitoring for treatment-related adverse events, according to research …

Feb 1, 2003 · The current trends in favor of androgen deprivation therapy (ADT) for nonmetastatic prostate cancer at the stage of biochemical recurrence or increasi…

Learn about hormone therapy for prostate cancer, including androgen deprivation therapy (ADT), which lowers male hormones and keeps prostate cancer cells from growing.

Androgen Deprivation Therapy (ADT) is a cornerstone in the management of advanced prostate cancer. However, monitoring the response to ADT and detecting the emergence of resistance remains a …

Aug 6, 2024 · The article provides an overview of androgen deprivation therapy for prostate cancer. Interfering with testosterone can slow the growth of prostate cancer but has significant side effects, …

Nov 12, 2025 · What Is Androgen Deprivation Therapy? Androgen deprivation therapy (ADT) is hormone therapy for advanced prostate cancer. Prostate cancer grows in the presence of male hormones …

Testosterone can be lowered through surgery or hormonal therapy, also known as androgen deprivation therapy (ADT). This therapy uses drugs to block or lower testosterone and other male sex hormones …